Efficacy and tolerability of alirocumab in Austrian clinical practice – results of the non-interventional PEARL-AT study
Sign Up to like & getrecommendations! Published in 2020 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2020.1786678
Abstract: Abstract Objective Proprotein convertase subtilisin/kexin type 9 inhibition can be an effective treatment in patients with primary hypercholesterolemia, particularly in cases with concomitant coronary heart disease, peripheral artery occlusive disease or cerebrovascular occlusive disease for… read more here.
Keywords: non interventional; real world; pearl study; study ... See more keywords